| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H19F2N5O4 |
| Molecular Weight | 407.3714 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](NC1=CC=C2C3=NC(=CN3CCOC2=C1)N4[C@@H](COC4=O)C(F)F)C(N)=O
InChI
InChIKey=SGEUNORSOZVTOL-CABZTGNLSA-N
InChI=1S/C18H19F2N5O4/c1-9(16(21)26)22-10-2-3-11-13(6-10)28-5-4-24-7-14(23-17(11)24)25-12(15(19)20)8-29-18(25)27/h2-3,6-7,9,12,15,22H,4-5,8H2,1H3,(H2,21,26)/t9-,12-/m0/s1
| Molecular Formula | C18H19F2N5O4 |
| Molecular Weight | 407.3714 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.038 nM [IC50] |
